Menu

 

The NASA Task Book
Advanced Search     

Project Title:  B Complex: 5-Methyltetrahydrofolate, Riboflavin, Pyridoxine, and Methylcobalamin Supplementation as a Non-Mechanical Countermeasure to Mitigate Optic Disc Edema Changes During Strict 6º Head-Down Tilt Bed Rest Reduce
Images: icon  Fiscal Year: FY 2024 
Division: Human Research 
Research Discipline/Element:
HRP HHC:Human Health Countermeasures
Start Date: 10/01/2019  
End Date: 09/30/2024  
Task Last Updated: 07/12/2023 
Download report in PDF pdf
Principal Investigator/Affiliation:   Zwart, Sara  Ph.D. / NASA Johnson Space Center 
Address:  Department of Preventive Medicine and Community Health 
2101 Nasa Pkwy, Mail Stop SK3 
Houston , TX 77058-3607 
Email: sara.zwart-1@nasa.gov 
Phone: 281-483-3753  
Congressional District: 36 
Web:  
Organization Type: NASA CENTER 
Organization Name: NASA Johnson Space Center 
Joint Agency:  
Comments:  
Co-Investigator(s)
Affiliation: 
Chen, John  M.D., Ph.D. Mayo Clinic Rochester 
Egert, Sarah  Ph.D. University of Hohenheim, Germany 
Heer, Martina  Ph.D. Rheinische Friedrich-Wilhelms-Universitat Bonn, Germany 
Laurie, Steven  Ph.D. KBR/NASA Johnson Space Center 
Macias, Brandon  Ph.D. NASA Johnson Space Center 
Smith, Scott  Ph.D. NASA Johnson Space Center 
Key Personnel Changes / Previous PI: No changes
Project Information: Grant/Contract No. Internal Project 
Responsible Center: NASA JSC 
Grant Monitor: Stenger, Michael  
Center Contact: 281-483-1311 
michael.b.stenger@nasa.gov 
Unique ID: 14185 
Solicitation / Funding Source: 2018-2019 HERO 80JSC018N0001-SANS: Spaceflight Associated Neuro-ocular Syndrome Countermeasures. Appendix C 
Grant/Contract No.: Internal Project 
Project Type: GROUND 
Flight Program:  
TechPort: No 
No. of Post Docs:
No. of PhD Candidates:
No. of Master's Candidates:
No. of Bachelor's Candidates:
No. of PhD Degrees:
No. of Master's Degrees:
No. of Bachelor's Degrees:
Human Research Program Elements: (1) HHC:Human Health Countermeasures
Human Research Program Risks: (1) SANS:Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS)
Human Research Program Gaps: (1) SANS-202:Determine if genetic/metabolic/anatomic dispositions and biomarkers, and sex differences have a contributing role in the development of ocular manifestations.
Flight Assignment/Project Notes: End date changed to 09/30/2024 per C. Ribeiro/HHC (Ed., 10/2/2023).

Task Description: NOTE: Per the Principal Investigator (PI), the study has been reduced to 4 campaigns (from 6 originally planned), and a proposed countermeasure – a B-vitamin supplement – was deselected from the study (Ed.,10/20/22).

Approximately 20% of astronauts on International Space Station (ISS) missions have experienced ophthalmic pathologies including optic disc edema, one aspect of what is characterized as Spaceflight Associated Neuro-ocular Syndrome, or SANS. While the precise cause for SANS is not known, it is likely that there are multiple contributing factors, including genetic and environmental factors that may affect the response to headward fluid shifts. B-vitamin status, one carbon biochemistry, and the presence of specific one-carbon metabolic pathway single nucleotide polymorphism (SNP) alleles were significant predictors for the incidence of astronaut ophthalmic pathologies, including optic disc edema, choroidal folds, and cotton wool spots. When looking at the individual SNPs, the G allele of methionine synthase reductase (MTRR, rs1801394) A66G and the C allele of serine hydroxymethyltransferase-1 (SHMT1, rs1979227) C1420T were associated with higher incidence of spaceflight-induced ophthalmic changes compared to those with the A or T alleles.

In ground-analog studies, end-tidal CO2, a reflection of arterial CO2, response to acute head-down tilt (HDT) and CO2 exposure was also related to G and C alleles of MTRR A66G and SHMT1 C1420T and B-vitamin status. Likewise, in a recent bed rest study where subjects were exposed to strict 6°-HDT bed rest and 0.5% CO2 for 30 days, 5 out of 11 subjects developed optic disc edema.

The number of SHMT1 C1420T C and MTRR A66G G alleles were significantly associated with the change in total retina thickness, a quantitative measure of optic disc edema. There are several possibilities to explain how one-carbon metabolism could lead to the ocular phenotypes in some individuals after spaceflight or bed rest. One-carbon metabolism is intimately involved in maintaining endothelial function through maintenance of endothelial nitric oxide (NO) synthase and NO production. We have proposed a multi-hit hypothesis, with genetics and B vitamin status, along with potential factors or “multiple hits” contributing to endothelial dysfunction (e.g., CO2 exposure, fluid shifts, altered endocrine function, radiation exposure). The resulting endothelial dysfunction could lead to cerebral microvascular edema, which can impede cerebrospinal fluid outflow and impinge on the optic nerve and eye.

Furthermore, decreased NO and increased peroxynitrite can also affect collagen and elastin integrity through activation of matrix metalloproteinases (MMPs). Specifically, MMP activation can affect collagen and elastin cross-linking, firmness, and elasticity, particularly in the sclera and lamina cribrosa, which are collagen-containing layers of the eye. Differences in elasticity of the sclera and lamina cribrosa could affect an individual’s response to a headward fluid shift during bed rest or spaceflight.

Dietary B-vitamin insufficiencies and variants in genes involved in the one-carbon metabolic pathway can contribute to pathway inefficiency, which can affect numerous outcomes, including NO production and endothelial function. This would also explain why after exposure to microgravity, fluid shift, CO2, and/or other factors – only a subset of individuals develop optic disc edema. We hypothesize here that supplementing with required cofactors (i.e., B-vitamins) can increase one-carbon pathway efficiency and ultimately prevent or mitigate spaceflight- and bed rest-induced optic disc edema.

Research Impact/Earth Benefits: The implications of this research for one of NASA’s highest priority crew health risks are significant, along with the implications for a better understanding of the role of one-carbon metabolism in the health of the general population.

Task Progress & Bibliography Information FY2024 
Task Progress: After receiving Authority to Proceed on August 30, 2019, the Institutional Revew Board (IRB) documentation was developed and submitted for review. IRB approval was obtained in May 2020 and a renewal was approved in April 2021.

The SANS Countermeasures study has been reduced to 4 campaigns (from 6 originally planned), and our proposed countermeasure – a B-vitamin supplement – was deselected from study. [Ed. Note: SANS is the acronym for Spaceflight Associated Neuro-ocular Syndrome.] This was due to the regulatory burden at the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt / DLR) that would be required to support this B-Complex study. The study would have been classified as a Clinical Trial, and DLR was not poised to support such a study. Despite the fact that the B-Complex supplement will not be tested in this study, all of the genetics and biochemistry analyses from our proposed study are still planned for the 4 campaigns and will provide valuable information. The current timeline for the 4 campaigns is:

• Campaign 1 and 2: lower body negative pressure (LBNP) and 6-hour seated (12 subjects per campaign) -- Campaign 1 baseline data collection (BDC) started on 9/28/21 and ended 12/1/21 -- Campaign 2 BDC started 1/24/22 and ended 3/29/22

• Campaign 3 and 4: exercise countermeasure (CM) and strict head-down tilt (HDT) (12 subjects per campaign) -- Campaign 3 started 1/23/23 and ended 3/28/23 -- Campaign 4 started 5/1/23 and ended 7/4/23

Blood samples from Campaigns 1-3 have been received. Blood samples from Campaign 4 are scheduled to be shipped in July 2023. Once samples are received, analyses will begin.

Bibliography: Description: (Last Updated: ) 

Show Cumulative Bibliography
 
 None in FY 2024
Project Title:  B Complex: 5-Methyltetrahydrofolate, Riboflavin, Pyridoxine, and Methylcobalamin Supplementation as a Non-Mechanical Countermeasure to Mitigate Optic Disc Edema Changes During Strict 6º Head-Down Tilt Bed Rest Reduce
Images: icon  Fiscal Year: FY 2023 
Division: Human Research 
Research Discipline/Element:
HRP HHC:Human Health Countermeasures
Start Date: 10/01/2019  
End Date: 02/28/2024  
Task Last Updated: 07/15/2022 
Download report in PDF pdf
Principal Investigator/Affiliation:   Zwart, Sara  Ph.D. / NASA Johnson Space Center 
Address:  Department of Preventive Medicine and Community Health 
2101 Nasa Pkwy, Mail Stop SK3 
Houston , TX 77058-3607 
Email: sara.zwart-1@nasa.gov 
Phone: 281-483-3753  
Congressional District: 36 
Web:  
Organization Type: NASA CENTER 
Organization Name: NASA Johnson Space Center 
Joint Agency:  
Comments:  
Co-Investigator(s)
Affiliation: 
Chen, John  M.D., Ph.D. Mayo Clinic Rochester 
Egert, Sarah  Ph.D. University of Hohenheim, Germany 
Heer, Martina  Ph.D. Rheinische Friedrich-Wilhelms-Universitat Bonn, Germany 
Laurie, Steven  Ph.D. KBR/NASA Johnson Space Center 
Macias, Brandon  Ph.D. NASA Johnson Space Center 
Smith, Scott  Ph.D. NASA Johnson Space Center 
Key Personnel Changes / Previous PI: No changes
Project Information: Grant/Contract No. Internal Project 
Responsible Center: NASA JSC 
Grant Monitor: Stenger, Michael  
Center Contact: 281-483-1311 
michael.b.stenger@nasa.gov 
Unique ID: 14185 
Solicitation / Funding Source: 2018-2019 HERO 80JSC018N0001-SANS: Spaceflight Associated Neuro-ocular Syndrome Countermeasures. Appendix C 
Grant/Contract No.: Internal Project 
Project Type: GROUND 
Flight Program:  
TechPort: No 
No. of Post Docs:
No. of PhD Candidates:
No. of Master's Candidates:
No. of Bachelor's Candidates:
No. of PhD Degrees:
No. of Master's Degrees:
No. of Bachelor's Degrees:
Human Research Program Elements: (1) HHC:Human Health Countermeasures
Human Research Program Risks: (1) SANS:Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS)
Human Research Program Gaps: (1) SANS-202:Determine if genetic/metabolic/anatomic dispositions and biomarkers, and sex differences have a contributing role in the development of ocular manifestations.
Task Description: NOTE: Per the Principal Investigator (PI), the study has been reduced to 4 campaigns (from 6 originally planned), and a proposed countermeasure – a B-vitamin supplement – was deselected from the study (Ed.,10/20/22).

Approximately 20% of astronauts on International Space Station (ISS) missions have experienced ophthalmic pathologies including optic disc edema, one aspect of what is characterized as Spaceflight Associated Neuro-ocular Syndrome, or SANS. While the precise cause for SANS is not known, it is likely that there are multiple contributing factors, including genetic and environmental factors that may affect the response to headward fluid shifts. B-vitamin status, one carbon biochemistry, and the presence of specific one-carbon metabolic pathway single nucleotide polymorphism (SNP) alleles were significant predictors for the incidence of astronaut ophthalmic pathologies, including optic disc edema, choroidal folds, and cotton wool spots. When looking at the individual SNPs, the G allele of methionine synthase reductase (MTRR, rs1801394) A66G and the C allele of serine hydroxymethyltransferase-1 (SHMT1, rs1979227) C1420T were associated with higher incidence of spaceflight-induced ophthalmic changes compared to those with the A or T alleles.

In ground-analog studies, end-tidal CO2, a reflection of arterial CO2, response to acute head-down tilt (HDT) and CO2 exposure was also related to G and C alleles of MTRR A66G and SHMT1 C1420T and B-vitamin status. Likewise, in a recent bed rest study where subjects were exposed to strict 6°-HDT bed rest and 0.5% CO2 for 30 days, 5 out of 11 subjects developed optic disc edema.

The number of SHMT1 C1420T C and MTRR A66G G alleles were significantly associated with the change in total retina thickness, a quantitative measure of optic disc edema. There are several possibilities to explain how one-carbon metabolism could lead to the ocular phenotypes in some individuals after spaceflight or bed rest. One-carbon metabolism is intimately involved in maintaining endothelial function through maintenance of endothelial nitric oxide (NO) synthase and NO production. We have proposed a multi-hit hypothesis, with genetics and B vitamin status, along with potential factors or “multiple hits” contributing to endothelial dysfunction (e.g., CO2 exposure, fluid shifts, altered endocrine function, radiation exposure). The resulting endothelial dysfunction could lead to cerebral microvascular edema, which can impede cerebrospinal fluid outflow and impinge on the optic nerve and eye.

Furthermore, decreased NO and increased peroxynitrite can also affect collagen and elastin integrity through activation of matrix metalloproteinases (MMPs). Specifically, MMP activation can affect collagen and elastin cross-linking, firmness, and elasticity, particularly in the sclera and lamina cribrosa, which are collagen-containing layers of the eye. Differences in elasticity of the sclera and lamina cribrosa could affect an individual’s response to a headward fluid shift during bed rest or spaceflight.

Dietary B-vitamin insufficiencies and variants in genes involved in the one-carbon metabolic pathway can contribute to pathway inefficiency, which can affect numerous outcomes, including NO production and endothelial function. This would also explain why after exposure to microgravity, fluid shift, CO2, and/or other factors – only a subset of individuals develop optic disc edema. We hypothesize here that supplementing with required cofactors (i.e., B-vitamins) can increase one-carbon pathway efficiency and ultimately prevent or mitigate spaceflight- and bed rest-induced optic disc edema.

Research Impact/Earth Benefits: The implications of this research for one of NASA’s highest priority crew health risks are significant, along with the implications for a better understanding of the role of one-carbon metabolism in the health of the general population.

Task Progress & Bibliography Information FY2023 
Task Progress: October 2022 Update (Ed., 10/20/22) --

After receiving Authority to Proceed on August 30, 2019, Institutional Review Board (IRB) documentation was developed and submitted for review. IRB approval was obtained in May 2020 and a renewal was approved in April 2021. The study has been reduced to 4 campaigns (from 6 originally planned), and our proposed countermeasure – a B-vitamin supplement – was deselected from the study. Despite the fact that the B-Complex supplement will not be tested in this study, all of the genetics and biochemistry analyses from our proposed study are still planned for the 4 campaigns and will provide valuable information to the development of SANS countermeasures.

Samples from the second Campaign are being shipped soon, and once samples are received, analyses will begin on Campaign 1 and 2 samples.

Bibliography: Description: (Last Updated: ) 

Show Cumulative Bibliography
 
 None in FY 2023
Project Title:  B Complex: 5-Methyltetrahydrofolate, Riboflavin, Pyridoxine, and Methylcobalamin Supplementation as a Non-Mechanical Countermeasure to Mitigate Optic Disc Edema Changes During Strict 6º Head-Down Tilt Bed Rest Reduce
Images: icon  Fiscal Year: FY 2022 
Division: Human Research 
Research Discipline/Element:
HRP HHC:Human Health Countermeasures
Start Date: 10/01/2019  
End Date: 02/28/2024  
Task Last Updated: 07/27/2021 
Download report in PDF pdf
Principal Investigator/Affiliation:   Zwart, Sara  Ph.D. / NASA Johnson Space Center 
Address:  Department of Preventive Medicine and Community Health 
2101 Nasa Pkwy, Mail Stop SK3 
Houston , TX 77058-3607 
Email: sara.zwart-1@nasa.gov 
Phone: 281-483-3753  
Congressional District: 36 
Web:  
Organization Type: NASA CENTER 
Organization Name: NASA Johnson Space Center 
Joint Agency:  
Comments:  
Co-Investigator(s)
Affiliation: 
Chen, John  M.D., Ph.D. Mayo Clinic Rochester 
Egert, Sarah  Ph.D. University of Hohenheim, Germany 
Heer, Martina  Ph.D. Rheinische Friedrich-Wilhelms-Universitat Bonn, Germany 
Laurie, Steven  Ph.D. KBR/NASA Johnson Space Center 
Macias, Brandon  Ph.D. NASA Johnson Space Center 
Smith, Scott  Ph.D. NASA Johnson Space Center 
Key Personnel Changes / Previous PI: No changes
Project Information: Grant/Contract No. Internal Project 
Responsible Center: NASA JSC 
Grant Monitor: Stenger, Michael  
Center Contact: 281-483-1311 
michael.b.stenger@nasa.gov 
Unique ID: 14185 
Solicitation / Funding Source: 2018-2019 HERO 80JSC018N0001-SANS: Spaceflight Associated Neuro-ocular Syndrome Countermeasures. Appendix C 
Grant/Contract No.: Internal Project 
Project Type: GROUND 
Flight Program:  
TechPort: No 
No. of Post Docs:
No. of PhD Candidates:
No. of Master's Candidates:
No. of Bachelor's Candidates:
No. of PhD Degrees:
No. of Master's Degrees:
No. of Bachelor's Degrees:
Human Research Program Elements: (1) HHC:Human Health Countermeasures
Human Research Program Risks: (1) SANS:Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS)
Human Research Program Gaps: (1) SANS-202:Determine if genetic/metabolic/anatomic dispositions and biomarkers, and sex differences have a contributing role in the development of ocular manifestations.
Task Description: Approximately 20% of astronauts on International Space Station (ISS) missions have experienced ophthalmic pathologies including optic disc edema, one aspect of what is characterized as Spaceflight Associated Neuro-ocular Syndrome, or SANS. While the precise cause for SANS is not known, it is likely that there are multiple contributing factors, including genetic and environmental factors that may affect the response to headward fluid shifts. B-vitamin status, one carbon biochemistry, and the presence of specific one-carbon metabolic pathway single nucleotide polymorphism (SNP) alleles were significant predictors for the incidence of astronaut ophthalmic pathologies, including optic disc edema, choroidal folds, and cotton wool spots. When looking at the individual SNPs, the G allele of methionine synthase reductase (MTRR, rs1801394) A66G and the C allele of serine hydroxymethyltransferase-1 (SHMT1, rs1979227) C1420T were associated with higher incidence of spaceflight-induced ophthalmic changes compared to those with the A or T alleles.

In ground-analog studies, end-tidal CO2, a reflection of arterial CO2, response to acute head-down tilt (HDT) and CO2 exposure was also related to G and C alleles of MTRR A66G and SHMT1 C1420T and B-vitamin status. Likewise, in a recent bed rest study where subjects were exposed to strict 6°-HDT bed rest and 0.5% CO2 for 30 days, 5 out of 11 subjects developed optic disc edema.

The number of SHMT1 C1420T C and MTRR A66G G alleles were significantly associated with the change in total retina thickness, a quantitative measure of optic disc edema. There are several possibilities to explain how one-carbon metabolism could lead to the ocular phenotypes in some individuals after spaceflight or bed rest. One-carbon metabolism is intimately involved in maintaining endothelial function through maintenance of endothelial nitric oxide (NO) synthase and NO production. We have proposed a multi-hit hypothesis, with genetics and B vitamin status, along with potential factors or “multiple hits” contributing to endothelial dysfunction (e.g., CO2 exposure, fluid shifts, altered endocrine function, radiation exposure). The resulting endothelial dysfunction could lead to cerebral microvascular edema, which can impede cerebrospinal fluid outflow and impinge on the optic nerve and eye.

Furthermore, decreased NO and increased peroxynitrite can also affect collagen and elastin integrity through activation of matrix metalloproteinases (MMPs). Specifically, MMP activation can affect collagen and elastin cross-linking, firmness, and elasticity, particularly in the sclera and lamina cribrosa, which are collagen-containing layers of the eye. Differences in elasticity of the sclera and lamina cribrosa could affect an individual’s response to a headward fluid shift during bed rest or spaceflight.

Dietary B-vitamin insufficiencies and variants in genes involved in the one-carbon metabolic pathway can contribute to pathway inefficiency, which can affect numerous outcomes, including NO production and endothelial function. This would also explain why after exposure to microgravity, fluid shift, CO2, and/or other factors – only a subset of individuals develop optic disc edema. We hypothesize here that supplementing with required cofactors (i.e., B-vitamins) can increase one-carbon pathway efficiency and ultimately prevent or mitigate spaceflight- and bed rest-induced optic disc edema.

Research Impact/Earth Benefits: The implications of this research for one of NASA’s highest priority crew health risks are significant, along with the implications for a better understanding of the role of one-carbon metabolism in the health of the general population.

Task Progress & Bibliography Information FY2022 
Task Progress: After receiving Authority to Proceed on August 30, 2019, Institutional Review Board (IRB) documentation was developed and submitted for review. IRB approval was obtained in May 2020 and a renewal was approved in April 2021.

The SANS Countermeasures selected for this study have been reduced to 4 campaigns (from 6 originally planned) due to the regulatory burden at DLR (German Aerospace Center) that would be required to support this B-Complex study. The study would have been classified as a Clinical Trial, and DLR was not poised to support such a study. The current timeline for the 4 campaigns is Campaign 1 and 2 – lower body negative pressure (LBNP) and 6-hour seated (12 subjects per campaign) – Campaign 1 baseline data collection (BDC) start 09/28/2021, Campaign 2 BDC start 01/24/2022; Campaign 3 and 4 – exercise CM (countermeasure) and strict head down tilt (HDT) (12 subjects per campaign) – Campaign 3 and 4 BDC start TBC but likely during 2023. Despite the fact that the B-Complex supplement will not be tested in this study, all of the genetics and biochemistry analyses from our proposed study are still planned for the 4 campaigns.

An Investigator’s Working Group meeting is scheduled for September 1, 2021.

Bibliography: Description: (Last Updated: ) 

Show Cumulative Bibliography
 
 None in FY 2022
Project Title:  B Complex: 5-Methyltetrahydrofolate, Riboflavin, Pyridoxine, and Methylcobalamin Supplementation as a Non-Mechanical Countermeasure to Mitigate Optic Disc Edema Changes During Strict 6º Head-Down Tilt Bed Rest Reduce
Images: icon  Fiscal Year: FY 2021 
Division: Human Research 
Research Discipline/Element:
HRP HHC:Human Health Countermeasures
Start Date: 10/01/2019  
End Date: 02/28/2024  
Task Last Updated: 12/15/2020 
Download report in PDF pdf
Principal Investigator/Affiliation:   Zwart, Sara  Ph.D. / NASA Johnson Space Center 
Address:  Department of Preventive Medicine and Community Health 
2101 Nasa Pkwy, Mail Stop SK3 
Houston , TX 77058-3607 
Email: sara.zwart-1@nasa.gov 
Phone: 281-483-3753  
Congressional District: 36 
Web:  
Organization Type: NASA CENTER 
Organization Name: NASA Johnson Space Center 
Joint Agency:  
Comments:  
Co-Investigator(s)
Affiliation: 
Chen, John  M.D., Ph.D. Mayo Clinic Rochester 
Egert, Sarah  Ph.D. University of Hohenheim, Germany 
Heer, Martina  Ph.D. Rheinische Friedrich-Wilhelms-Universitat Bonn, Germany 
Laurie, Steven  Ph.D. KBR/NASA Johnson Space Center 
Macias, Brandon  Ph.D. NASA Johnson Space Center 
Smith, Scott  Ph.D. NASA Johnson Space Center 
Key Personnel Changes / Previous PI: No changes
Project Information: Grant/Contract No. Internal Project 
Responsible Center: NASA JSC 
Grant Monitor: Stenger, Michael  
Center Contact: 281-483-1311 
michael.b.stenger@nasa.gov 
Unique ID: 14185 
Solicitation / Funding Source: 2018-2019 HERO 80JSC018N0001-SANS: Spaceflight Associated Neuro-ocular Syndrome Countermeasures. Appendix C 
Grant/Contract No.: Internal Project 
Project Type: GROUND 
Flight Program:  
TechPort: No 
No. of Post Docs:
No. of PhD Candidates:
No. of Master's Candidates:
No. of Bachelor's Candidates:
No. of PhD Degrees:
No. of Master's Degrees:
No. of Bachelor's Degrees:
Human Research Program Elements: (1) HHC:Human Health Countermeasures
Human Research Program Risks: (1) SANS:Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS)
Human Research Program Gaps: (1) SANS-202:Determine if genetic/metabolic/anatomic dispositions and biomarkers, and sex differences have a contributing role in the development of ocular manifestations.
Task Description: Approximately 20% of astronauts on International Space Station (ISS) missions have experienced ophthalmic pathologies including optic disc edema, one aspect of what is characterized as Spaceflight Associated Neuro-ocular Syndrome, or SANS. While the precise cause for SANS is not known, it is likely that there are multiple contributing factors, including genetic and environmental factors that may affect the response to headward fluid shifts. B-vitamin status, one carbon biochemistry, and the presence of specific one-carbon metabolic pathway single nucleotide polymorphism (SNP) alleles were significant predictors for the incidence of astronaut ophthalmic pathologies, including optic disc edema, choroidal folds, and cotton wool spots. When looking at the individual SNPs, the G allele of methionine synthase reductase (MTRR, rs1801394) A66G and the C allele of serine hydroxymethyltransferase-1 (SHMT1, rs1979227) C1420T were associated with higher incidence of spaceflight-induced ophthalmic changes compared to those with the A or T alleles.

In ground-analog studies, end-tidal CO2, a reflection of arterial CO2, response to acute head-down tilt (HDT) and CO2 exposure was also related to G and C alleles of MTRR A66G and SHMT1 C1420T and B-vitamin status. Likewise, in a recent bed rest study where subjects were exposed to strict 6°-HDT bed rest and 0.5% CO2 for 30 days, 5 out of 11 subjects developed optic disc edema.

The number of SHMT1 C1420T C and MTRR A66G G alleles were significantly associated with the change in total retina thickness, a quantitative measure of optic disc edema. There are several possibilities to explain how one-carbon metabolism could lead to the ocular phenotypes in some individuals after spaceflight or bed rest. One-carbon metabolism is intimately involved in maintaining endothelial function through maintenance of endothelial nitric oxide (NO) synthase and NO production. We have proposed a multi-hit hypothesis, with genetics and B vitamin status, along with potential factors or “multiple hits” contributing to endothelial dysfunction (e.g., CO2 exposure, fluid shifts, altered endocrine function, radiation exposure). The resulting endothelial dysfunction could lead to cerebral microvascular edema, which can impede cerebrospinal fluid outflow and impinge on the optic nerve and eye.

Furthermore, decreased NO and increased peroxynitrite can also affect collagen and elastin integrity through activation of matrix metalloproteinases (MMPs). Specifically, MMP activation can affect collagen and elastin cross-linking, firmness, and elasticity, particularly in the sclera and lamina cribrosa, which are collagen-containing layers of the eye. Differences in elasticity of the sclera and lamina cribrosa could affect an individual’s response to a headward fluid shift during bed rest or spaceflight.

Dietary B-vitamin insufficiencies and variants in genes involved in the one-carbon metabolic pathway can contribute to pathway inefficiency, which can affect numerous outcomes, including NO production and endothelial function. This would also explain why after exposure to microgravity, fluid shift, CO2, and/or other factors – only a subset of individuals develop optic disc edema. We hypothesize here that supplementing with required cofactors (i.e., B-vitamins) can increase one-carbon pathway efficiency and ultimately prevent or mitigate spaceflight- and bed rest-induced optic disc edema.

Research Impact/Earth Benefits: The implications of this research for one of NASA’s highest priority crew health risks are significant, along with the implications for a better understanding of the role of one-carbon metabolism in the health of the general population.

Task Progress & Bibliography Information FY2021 
Task Progress: The first 2 study arms are scheduled to start in the spring of 2021 at DLR’s (German Aerospace Center) :envihab facility.

Bibliography: Description: (Last Updated: ) 

Show Cumulative Bibliography
 
 None in FY 2021
Project Title:  B Complex: 5-Methyltetrahydrofolate, Riboflavin, Pyridoxine, and Methylcobalamin Supplementation as a Non-Mechanical Countermeasure to Mitigate Optic Disc Edema Changes During Strict 6º Head-Down Tilt Bed Rest Reduce
Images: icon  Fiscal Year: FY 2020 
Division: Human Research 
Research Discipline/Element:
HRP HHC:Human Health Countermeasures
Start Date: 10/01/2019  
End Date: 02/28/2024  
Task Last Updated: 12/08/2020 
Download report in PDF pdf
Principal Investigator/Affiliation:   Zwart, Sara  Ph.D. / NASA Johnson Space Center 
Address:  Department of Preventive Medicine and Community Health 
2101 Nasa Pkwy, Mail Stop SK3 
Houston , TX 77058-3607 
Email: sara.zwart-1@nasa.gov 
Phone: 281-483-3753  
Congressional District: 36 
Web:  
Organization Type: NASA CENTER 
Organization Name: NASA Johnson Space Center 
Joint Agency:  
Comments:  
Co-Investigator(s)
Affiliation: 
Chen, John  M.D., Ph.D. Mayo Clinic Rochester 
Egert, Sarah  Ph.D. University of Hohenheim, Germany 
Heer, Martina  Ph.D. Rheinische Friedrich-Wilhelms-Universitat Bonn, Germany 
Laurie, Steven  Ph.D. KBR/NASA Johnson Space Center 
Macias, Brandon  Ph.D. KBR/NASA Johnson Space Center 
Smith, Scott  Ph.D. NASA Johnson Space Center 
Project Information: Grant/Contract No. Internal Project 
Responsible Center: NASA JSC 
Grant Monitor:  
Center Contact:   
Unique ID: 14185 
Solicitation / Funding Source: 2018-2019 HERO 80JSC018N0001-SANS: Spaceflight Associated Neuro-ocular Syndrome Countermeasures. Appendix C 
Grant/Contract No.: Internal Project 
Project Type: GROUND 
Flight Program:  
TechPort: No 
No. of Post Docs:  
No. of PhD Candidates:  
No. of Master's Candidates:  
No. of Bachelor's Candidates:  
No. of PhD Degrees:  
No. of Master's Degrees:  
No. of Bachelor's Degrees:  
Human Research Program Elements: (1) HHC:Human Health Countermeasures
Human Research Program Risks: (1) SANS:Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS)
Human Research Program Gaps: (1) SANS-202:Determine if genetic/metabolic/anatomic dispositions and biomarkers, and sex differences have a contributing role in the development of ocular manifestations.
Task Description: Approximately 20% of astronauts on International Space Station (ISS) missions have experienced ophthalmic pathologies including optic disc edema, one aspect of what is characterized as Spaceflight Associated Neuro-ocular Syndrome, or SANS. While the precise cause for SANS is not known, it is likely that there are multiple contributing factors, including genetic and environmental factors that may affect the response to headward fluid shifts. B-vitamin status, one carbon biochemistry, and the presence of specific one-carbon metabolic pathway single nucleotide polymorphism (SNP) alleles were significant predictors for the incidence of astronaut ophthalmic pathologies, including optic disc edema, choroidal folds, and cotton wool spots. When looking at the individual SNPs, the G allele of methionine synthase reductase (MTRR, rs1801394) A66G and the C allele of serine hydroxymethyltransferase-1 (SHMT1, rs1979227) C1420T were associated with higher incidence of spaceflight-induced ophthalmic changes compared to those with the A or T alleles.

In ground-analog studies, end-tidal CO2, a reflection of arterial CO2, response to acute head-down tilt (HDT) and CO2 exposure was also related to G and C alleles of MTRR A66G and SHMT1 C1420T and B-vitamin status. Likewise, in a recent bed rest study where subjects were exposed to strict 6°-HDT bed rest and 0.5% CO2 for 30 days, 5 out of 11 subjects developed optic disc edema.

The number of SHMT1 C1420T C and MTRR A66G G alleles were significantly associated with the change in total retina thickness, a quantitative measure of optic disc edema. There are several possibilities to explain how one-carbon metabolism could lead to the ocular phenotypes in some individuals after spaceflight or bed rest. One-carbon metabolism is intimately involved in maintaining endothelial function through maintenance of endothelial nitric oxide (NO) synthase and NO production. We have proposed a multi-hit hypothesis, with genetics and B vitamin status, along with potential factors or “multiple hits” contributing to endothelial dysfunction (e.g., CO2 exposure, fluid shifts, altered endocrine function, radiation exposure). The resulting endothelial dysfunction could lead to cerebral microvascular edema, which can impede cerebrospinal fluid outflow and impinge on the optic nerve and eye.

Furthermore, decreased NO and increased peroxynitrite can also affect collagen and elastin integrity through activation of matrix metalloproteinases (MMPs). Specifically, MMP activation can affect collagen and elastin cross-linking, firmness, and elasticity, particularly in the sclera and lamina cribrosa, which are collagen-containing layers of the eye. Differences in elasticity of the sclera and lamina cribrosa could affect an individual’s response to a headward fluid shift during bed rest or spaceflight.

Dietary B-vitamin insufficiencies and variants in genes involved in the one-carbon metabolic pathway can contribute to pathway inefficiency, which can affect numerous outcomes, including NO production and endothelial function. This would also explain why after exposure to microgravity, fluid shift, CO2, and/or other factors – only a subset of individuals develop optic disc edema. We hypothesize here that supplementing with required cofactors (i.e., B-vitamins) can increase one-carbon pathway efficiency and ultimately prevent or mitigate spaceflight- and bed rest-induced optic disc edema.

Research Impact/Earth Benefits:

Task Progress & Bibliography Information FY2020 
Task Progress: New project for FY2020.

Bibliography: Description: (Last Updated: ) 

Show Cumulative Bibliography
 
 None in FY 2020